| mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0019 |
1 |
| mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
-0.002 |
1 |
| mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.0023 |
1 |
| mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
0.0016 |
1 |
| mRNA |
Cytarabine |
FIMM |
pan-cancer |
AAC |
-0.0066 |
1 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0014 |
1 |
| mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
0.0014 |
1 |
| mRNA |
S-Trityl-L-cysteine |
FIMM |
pan-cancer |
AAC |
0.0061 |
1 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0013 |
1 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.00085 |
1 |